Press release
Dengue Vaccine Market Size, Share, Growth and Trends, Report 2024-2031
Dengue Vaccine Market || 2024-2031
Dengue is a mosquito-borne illness caused by the dengue virus, which is part of the Flaviviridae family and the Flavivirus genus. Commonly referred to as "breakbone fever" or "dandy fever," dengue primarily spreads from human to human through the bite of an infected Aedes aegypti mosquito.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/dengue-vaccine-market
Market Dynamics:
Increasing Collaborations by the Research Institutes for the Clinical Trials of the Dengue Vaccine is Expected to Drive Market Growth.
In response to the rising incidence of dengue cases across the country, the Indian Council of Medical Research (ICMR) has initiated efforts to advance the development of a dengue vaccine. The ICMR is encouraging vaccine developers and pharmaceutical companies that have either developed or licensed tetravalent dengue vaccine candidates and have completed Phase I and Phase II clinical trials to collaborate with them for Phase III trials and further vaccine development.
The ICMR will provide institutional infrastructure for research and development (R&D) and Phase III clinical trials to evaluate the efficacy, safety, and immunogenicity of these tetravalent dengue vaccine candidates. For example, on March 4, 2022, the ICMR invited expressions of interest from Indian manufacturers with potential tetravalent vaccine candidates or non-exclusive licenses who are looking to conduct field studies as part of Phase III clinical trials.
This collaboration between vaccine manufacturers and the ICMR is expected to significantly drive the dengue vaccine market in the forecast period.
Segment Covered in Dengue Vaccine Market:
By Product Type: CYD-TDV.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dengue-vaccine-market
Key players involved in Dengue Vaccine Market:
• Sanofi
• Panacea Biotec
• Biological
• E. Limited
• GlaxoSmithKline plc
• Merck & Co.
• Takeda Pharmaceutical Company Ltd
• Vabiotec
• Panacea Biotec
• Medigen Biologics
*Note:
• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
Regional Analysis:
The Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dengue Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Related Reports:
Foam Dressings Market: https://www.datamintelligence.com/research-report/global-foam-dressings-market
Clinical Trials Market: https://www.datamintelligence.com/research-report/clinical-trials-market
Skin Cancer Market: https://www.datamintelligence.com/research-report/skin-cancer-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Vaccine Market Size, Share, Growth and Trends, Report 2024-2031 here
News-ID: 3656723 • Views: …
More Releases from DataM Intelligence 4Market Research
Pedicle Screw Systems Market is projected to reach up to US$ 2.9 million by 2030 …
Market Size and Growth:
The Global Pedicle Screw Systems Market reached US$ 2.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.9 million by 2030, The market is expected to exhibit a CAGR of 4.3% during the forecast period (2024-2031). The Market is growing due to the rising prevalence of spinal disorders and increasing demand for minimally invasive spinal surgeries. According to DataM Intelligence
Get…
Healthcare Services Market is expected to reach US$ 1,563.55 Billion by 2033 | T …
Market Size and Growth:
The Global Healthcare Services Market Size reached US$ 831.57 Billion in 2023, with a rise of US$ 882.21 Billion in 2024 and is expected to reach US$ 1,563.55 Billion by 2033, growing at a CAGR of 6.6% during the forecast period 2025-2033. The Market is growing due to rising healthcare demand, aging populations, and increased adoption of advanced medical technologies worldwide. According to DataM Intelligence
Get a Free…
Sensors in Mobile Phone Market is expected to reach US$ 20.1 billion by 2030 | M …
Market Size and Growth:
The Global Sensors in Mobile Phone Market Size reached US$ 12.8 billion in 2022 and is expected to reach US$ 20.1 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2024-2031. The Market is growing due to increasing smartphone adoption, rising demand for advanced features like AI and AR, and the integration of multiple sensors for enhanced user experience. According to DataM Intelligence
Get…
Phytogenic Feed Additives Market is expected to reach USD 1585.1 million by 2030 …
Market Size and Growth:
The Global Phytogenic Feed Additives Market reached USD 869.2 million in 2022 and is expected to reach USD 1585.1 million by 2030, growing with a CAGR of 7.8% during the forecast period 2024-2031. The Market is growing due to increasing demand for natural, antibiotic-free feed additives that enhance animal health and productivity. According to DataM Intelligence
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/phytogenic-feed-additives-market?sz
The Phytogenic Feed Additives Market involves…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
